Moneycontrol Be a Pro
Get App
powered by
BJP+ : 141

Need 4 more seats to win

INC+ : 89

Need 56 more seats to win

BJP : 39

Need 7 more seats to win

INC : 31

Need 15 more seats to win

*Wins + Leads
Last Updated : Jan 28, 2019 05:40 PM IST | Source:

Buy Jyothy Laboratories; target of Rs 225: Sharekhan

Sharekhan is bullish on Jyothy Laboratories has recommended buy rating on the stock with a target price of Rs 225 in its research report dated January 24, 2019.

Broker Research @moneycontrolcom
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Jyothy Laboratories

In Q3FY19, Jyothy Laboratories (JLL) posted muted operating performance with revenues and operating profit growing by 6.3% y-o-y and 5% y-o-y respectively. The lower growth in Ujala Fabric Whitener and decline in Margo revenues led to lower revenue growth during the quarter. The recovery in the household insecticide performance and strong growth in the Henko portfolio provides visibility of double digit growth in the coming quarters. The OPM is expected to sustain at about 16%.


We maintain our Buy recommendation on the stock with revised TP of Rs. 225 in view of discounted valuations at ~24x FY2021E earnings and expected recovery in performance in the coming quarters.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Assembly Election 2019 Results Updates:
Catch Maharashtra Election Result 2019 updates, news and views here
Catch Haryana Election Result 2019 updates, news and views here
Catch Bypoll Results 2019 updates, news and views here

For full coverage, click here.

The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .
First Published on Jan 28, 2019 05:40 pm
Follow us on
Available On